Innovative Procedures V. Premarketing Approval
The U.S. Food and Drug Administration is increasingly scrutinizing certain novel stem cell and tissue procedures used by physicians and companies, asserting that such activities do not comply with the Food,...To view the full article, register now.
Already a subscriber? Click here to view full article